(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIVERE DRIP THERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VIVERE DRIP THERAPY

ST13

US500000097893591

Class

44

Filing

97893591

Registration

7629570

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

12/31/2024

Trademark type

Word

Nice classes

44

Filing date

04/18/2023

Registration date

12/31/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/31/2024

Last transaction

12/31/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/01/2023

First use in commerce

01/01/2023

Drawing code

4

Owner type

01

Owner location

Salinas, CA

Examiner

CRAVEN, PAUL S

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Baylis, Anne M.

Representatives

Phillip Thomas Horton THE RAPACKE LAW GROUP, P.A.

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Health care servicesintravenous (IV) hydration therapy and telehealth services; Therapy services featuring intravenous (IV) hydration services with vitamins and telehealth services; Intravenous (IV) hydration therapy services

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/31/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/31/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2024

PUBO

PUBLISHED FOR OPPOSITION

11/12/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2024

ALIE

ASSIGNED TO LIE

10/01/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/07/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/08/2024

GNFR

FINAL REFUSAL E-MAILED

05/08/2024

CNFR

FINAL REFUSAL WRITTEN

05/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/17/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/17/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/17/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/17/2024

GNRT

NON-FINAL ACTION E-MAILED

01/17/2024

CNRT

NON-FINAL ACTION WRITTEN

01/17/2024

RFTP

REMOVED FROM TEAS PLUS

01/17/2024

DOCK

ASSIGNED TO EXAMINER

01/16/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/12/2023

NWAP

NEW APPLICATION ENTERED

04/21/2023

Continuous trademark protection

Get notified about every new filing that threatens VIVERE DRIP THERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.